nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A Conceptual Framework and Key Research Questions in Educational Needs of Blood and Marrow Transplantation Patients, Caregivers, and Families
|
Schoemans, Helene M. |
|
2019 |
25 |
7 |
p. 1416-1423 |
artikel |
2 |
Allogeneic Transplantation after Myeloablative Rituximab/BEAM ± Bortezomib for Patients with Relapsed/Refractory Lymphoid Malignancies: 5-Year Follow-Up Results
|
Chamoun, Kamal |
|
2019 |
25 |
7 |
p. 1347-1354 |
artikel |
3 |
A Phase I/II, Open-Label, Prospective, Multicenter Study to Evaluate the Efficacy and Safety of Lower Doses of Bortezomib Plus Busulfan and Melphalan as a Conditioning Regimen in Patients with Multiple Myeloma Undergoing Autologous Peripheral Blood Stem Cell Transplantation: The KMM103 Study
|
Park, Sung-Soo |
|
2019 |
25 |
7 |
p. 1312-1319 |
artikel |
4 |
Association of Antiepileptic Medications with Outcomes after Allogeneic Hematopoietic Cell Transplantation with Busulfan/Cyclophosphamide Conditioning
|
McCune, Jeannine S. |
|
2019 |
25 |
7 |
p. 1424-1431 |
artikel |
5 |
ASTCT Notes
|
|
|
2019 |
25 |
7 |
p. 1472-1473 |
artikel |
6 |
Changes in Immunosuppressive Treatment of Chronic Graft-versus-Host Disease: Comparison of 2 Surveys within Allogeneic Hematopoietic Stem Cell Transplant Centers in Germany, Austria, and Switzerland
|
Wolff, Daniel |
|
2019 |
25 |
7 |
p. 1450-1455 |
artikel |
7 |
Clearance of Hematologic Malignancies by Allogeneic Cytokine-Induced Killer Cell or Donor Lymphocyte Infusions
|
Merker, Michael |
|
2019 |
25 |
7 |
p. 1281-1292 |
artikel |
8 |
Comparing a Neutropenic Diet to a Food Safety-Based Diet in Pediatric Patients Undergoing Hematopoietic Stem Cell Transplantation
|
Taggart, Cynthia |
|
2019 |
25 |
7 |
p. 1382-1386 |
artikel |
9 |
Comparison of Graft Acquisition and Early Direct Charges of Haploidentical Related Donor Transplantation versus Umbilical Cord Blood Transplantation
|
Kanate, Abraham S. |
|
2019 |
25 |
7 |
p. 1456-1464 |
artikel |
10 |
Donor-Derived Cytokine-Induced Killer Cell Infusion as Consolidation after Nonmyeloablative Allogeneic Transplantation for Myeloid Neoplasms
|
Narayan, Rupa |
|
2019 |
25 |
7 |
p. 1293-1303 |
artikel |
11 |
Donor-Derived Cytokine-Induced Killer Cells after Nonmyeloablative Transplant for Myeloid Neoplasms
|
Lamb, Margaret G. |
|
2019 |
25 |
7 |
p. e221-e222 |
artikel |
12 |
Donor Lymphocyte Infusions versus Cytokine-Induced Killer Cells for Hematologic Malignancies after Transplantation
|
Lamb, Margaret G. |
|
2019 |
25 |
7 |
p. e219-e220 |
artikel |
13 |
Donor-Specific Anti-HLA Antibodies in Haploidentical Stem Cell Transplantation with Post-Transplantation Cyclophosphamide: Risk of Graft Failure, Poor Graft Function, and Impact on Outcomes
|
Bramanti, Stefania |
|
2019 |
25 |
7 |
p. 1395-1406 |
artikel |
14 |
Editorial Board
|
|
|
2019 |
25 |
7 |
p. A10 |
artikel |
15 |
Eltrombopag for Treating Thrombocytopenia after Allogeneic Stem Cell Transplantation
|
Yuan, Cai |
|
2019 |
25 |
7 |
p. 1320-1324 |
artikel |
16 |
Etoposide + Granulocyte Colony-Stimulating Factor and Optional Plerixafor in Patients Who Failed Chemomobilization with or without Plerixafor
|
Zucenka, Andrius |
|
2019 |
25 |
7 |
p. 1304-1311 |
artikel |
17 |
Haploidentical Hematopoietic Stem Cell Transplantation with Post-Transplant Cyclophosphamide for Primary Immunodeficiencies and Inherited Disorders in Children
|
Neven, Bénédicte |
|
2019 |
25 |
7 |
p. 1363-1373 |
artikel |
18 |
Hematopoietic Cell Transplantation for Paroxysmal Nocturnal Hemoglobinuria in the Age of Eculizumab
|
Cooper, Jason P. |
|
2019 |
25 |
7 |
p. 1331-1339 |
artikel |
19 |
Hematopoietic Stem Cell Transplantation for Mucopolysaccharidoses: Past, Present, and Future
|
Taylor, Madeleine |
|
2019 |
25 |
7 |
p. e226-e246 |
artikel |
20 |
Impact of Donor Type and Melphalan Dose on Allogeneic Transplantation Outcomes for Patients with Lymphoma
|
Saini, Neeraj Y. |
|
2019 |
25 |
7 |
p. 1340-1346 |
artikel |
21 |
Influence of Donor and Recipient Gender on Telomere Maintenance after Umbilical Cord Blood Cell Transplantation: A Study by the Gruppo Italiano Trapianto Di Midollo Osseo
|
Derenzini, Enrico |
|
2019 |
25 |
7 |
p. 1387-1394 |
artikel |
22 |
Influence of Donor Type (Sibling versus Matched Unrelated Donor versus Haploidentical Donor) on Outcomes after Clofarabine-Based Reduced-Intensity Conditioning Allograft for Myeloid Malignancies
|
Bouard, Louise |
|
2019 |
25 |
7 |
p. 1465-1471 |
artikel |
23 |
Low Exposure Busulfan Conditioning to Achieve Sufficient Multilineage Chimerism in Patients with Severe Combined Immunodeficiency
|
Dvorak, Christopher C. |
|
2019 |
25 |
7 |
p. 1355-1362 |
artikel |
24 |
Masthead (Purpose and Scope)
|
|
|
2019 |
25 |
7 |
p. A9 |
artikel |
25 |
Neutropenic Dietary Restrictions for Hematopoietic Stem Cell Patients: Time for a Change
|
Moody, Karen |
|
2019 |
25 |
7 |
p. e223-e225 |
artikel |
26 |
Officers and Directors of ASBMT
|
|
|
2019 |
25 |
7 |
p. A13 |
artikel |
27 |
Reduced Plasma Amino Acid Levels During Allogeneic Hematopoietic Stem Cell Transplantation Are Associated with Systemic Inflammation and Treatment-Related Complications
|
Weischendorff, Sarah |
|
2019 |
25 |
7 |
p. 1432-1440 |
artikel |
28 |
Risk Factors and Predictive Scoring System For Post-Transplant Lymphoproliferative Disorder after Hematopoietic Stem Cell Transplantation
|
Fujimoto, Ayumi |
|
2019 |
25 |
7 |
p. 1441-1449 |
artikel |
29 |
Risk Factors for Development of and Progression of Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome
|
Corbacioglu, Selim |
|
2019 |
25 |
7 |
p. 1271-1280 |
artikel |
30 |
Screening for Family Psychosocial Risk in Pediatric Hematopoietic Stem Cell Transplantation with the Psychosocial Assessment Tool
|
Pai, Ahna L.H. |
|
2019 |
25 |
7 |
p. 1374-1381 |
artikel |
31 |
Table of Contents
|
|
|
2019 |
25 |
7 |
p. A15-A19 |
artikel |
32 |
The Concentration of Total Nucleated Cells in Harvested Bone Marrow for Transplantation Has Decreased over Time
|
Prokopishyn, Nicole L. |
|
2019 |
25 |
7 |
p. 1325-1330 |
artikel |
33 |
Thiotepa, Busulfan, and Fludarabine Conditioning Regimen in T Cell-Replete HLA-Haploidentical Hematopoietic Stem Cell Transplantation
|
Duléry, Rémy |
|
2019 |
25 |
7 |
p. 1407-1415 |
artikel |